Millions of adults use Ozempic, Wegovy, and Mounjaro for weight loss and chronic conditions.
These medications have shown effectiveness and can also reduce alcohol and drug consumption and heart attack risk.
However, access is not equal, with some obtaining them through healthcare providers and others using online platforms without prescriptions.
The cost can be prohibitive, with Ozempic costing up to $1,000 per month without insurance.
This discussion explores the latest on these medications, including their uses, effects, and access.
Millions of adults take popular drugs like Ozempic, Wegovy, and Mounjaro to treat chronic conditions and/or lose weight.
Author's summary: Exploring access to Ozempic and GLP-1 medications for weight loss and chronic conditions.